Terms: = Skin cancer AND ACVR1, SKR1, 90, ENSG00000115170, Q04771, ACVRLK2, FOP, ALK2, ACTRI AND Clinical Outcome
43 results:
1. Characterization and dynamics of the soluble immunological microenvironment in melanoma patients undergoing radiotherapy.
Oertel M; Borrmann K; Baehr A; Eich HT; Greve B
Radiat Oncol; 2022 Nov; 17(1):194. PubMed ID: 36443849
[TBL] [Abstract] [Full Text] [Related]
2. Liver metastasis in uveal melanoma - treatment options and clinical outcome.
Kaštelan S; Mrazovac Zimak D; Ivanković M; Marković I; Gverović Antunica A
Front Biosci (Landmark Ed); 2022 Feb; 27(2):72. PubMed ID: 35227015
[TBL] [Abstract] [Full Text] [Related]
3. Hypofractionated radiotherapy in ten fractions for postmastectomy patients: a phase II study compared with another hypofractionation schedule with sixteen fractions.
Jiang H; Meng L; Zhang H; Dai X; Zhang Q; Ju Z; Yu W; Ma L
BMC Cancer; 2021 Dec; 21(1):1284. PubMed ID: 34852776
[TBL] [Abstract] [Full Text] [Related]
4. Blood-based extracellular matrix biomarkers are correlated with clinical outcome after PD-1 inhibition in patients with metastatic melanoma.
Hurkmans DP; Jensen C; Koolen SLW; Aerts J; Karsdal MA; Mathijssen RHJ; Willumsen N
J Immunother Cancer; 2020 Oct; 8(2):. PubMed ID: 33093157
[TBL] [Abstract] [Full Text] [Related]
5.
Wong A; Callahan J; Keyaerts M; Neyns B; Mangana J; Aberle S; Herschtal A; Fullerton S; Milne D; Iravani A; McArthur GA; Hicks RJ
Cancer Imaging; 2020 May; 20(1):36. PubMed ID: 32408884
[TBL] [Abstract] [Full Text] [Related]
6. Molecular risk prediction in cutaneous melanoma: A meta-analysis of the 31-gene expression profile prognostic test in 1,479 patients.
Greenhaw BN; Covington KR; Kurley SJ; Yeniay Y; Cao NA; Plasseraud KM; Cook RW; Hsueh EC; Gastman BR; Wei ML
J Am Acad Dermatol; 2020 Sep; 83(3):745-753. PubMed ID: 32229276
[TBL] [Abstract] [Full Text] [Related]
7. Relation of cetuximab-induced skin toxicity and early tumor shrinkage in metastatic colorectal cancer patients: results of the randomized phase 3 trial FIRE-3 (AIO KRK0306).
Holch JW; Held S; Stintzing S; Fischer von Weikersthal L; Decker T; Kiani A; Kaiser F; Heintges T; Kahl C; Kullmann F; Scheithauer W; Moehler M; von Einem JC; Michl M; Heinemann V
Ann Oncol; 2020 Jan; 31(1):72-78. PubMed ID: 31912799
[TBL] [Abstract] [Full Text] [Related]
8. Pigmentation of conjunctival melanoma recurrences and outcome.
Brouwer NJ; Marinkovic M; Luyten GPM; Shields CL; Jager MJ
Graefes Arch Clin Exp Ophthalmol; 2019 Aug; 257(8):1783-1788. PubMed ID: 31098751
[TBL] [Abstract] [Full Text] [Related]
9. Associations between skin rash, treatment outcome, and single nucleotide polymorphisms in head and neck cancer patients receiving the EGFR-inhibitor zalutumumab: results from the DAHANCA 19 trial.
Brøndum L; Alsner J; Sørensen BS; Maare C; Johansen J; Primdahl H; Evensen JF; Kristensen CA; Andersen LJ; Overgaard J; Eriksen JG
Acta Oncol; 2018 Sep; 57(9):1159-1164. PubMed ID: 29771169
[TBL] [Abstract] [Full Text] [Related]
10. Treatment outcomes and HPV characteristics for an institutional cohort of patients with anal cancer receiving concurrent chemotherapy and intensity-modulated radiation therapy.
Foster CC; Lee AY; Furtado LV; Hart J; Alpert L; Xiao SY; Hyman NH; Sharma MR; Liauw SL
PLoS One; 2018; 13(3):e0194234. PubMed ID: 29522569
[TBL] [Abstract] [Full Text] [Related]
11. Treatment of conjunctival melanoma in a Dutch referral centre.
Brouwer NJ; Marinkovic M; van Duinen SG; Bleeker JC; Jager MJ; Luyten GPM
Br J Ophthalmol; 2018 Sep; 102(9):1277-1282. PubMed ID: 29122819
[TBL] [Abstract] [Full Text] [Related]
12. Favorable outcome with Close Margins in Patients Undergoing Nipple/skin Sparing Mastectomy with Immediate Breast Reconstruction: 5-year Follow-up.
Özkurt E; Tükenmez M; Güven E; Çelet Özden B; Öner G; Müslümanoğlu M; İğci A; Özmen V; Küçücük S; Cabioğlu N
Balkan Med J; 2018 Jan; 35(1):84-92. PubMed ID: 28958980
[TBL] [Abstract] [Full Text] [Related]
13. Survivin: A novel marker and potential therapeutic target for human angiosarcoma.
Tsuneki M; Kinjo T; Mori T; Yoshida A; Kuyama K; Ohira A; Miyagi T; Takahashi K; Kawai A; Chuman H; Yamazaki N; Masuzawa M; Arakawa H
Cancer Sci; 2017 Nov; 108(11):2295-2305. PubMed ID: 28845553
[TBL] [Abstract] [Full Text] [Related]
14. Polymorphisms of the stem cell marker gene
Liu QF; Zhang ZF; Hou GJ; Yang GY; He Y
BMJ Open; 2017 Aug; 7(8):e016913. PubMed ID: 28827262
[TBL] [Abstract] [Full Text] [Related]
15. Immune-Related Gene Expression Profiling After PD-1 Blockade in Non-Small Cell Lung Carcinoma, Head and Neck Squamous Cell Carcinoma, and Melanoma.
Prat A; Navarro A; Paré L; Reguart N; Galván P; Pascual T; Martínez A; Nuciforo P; Comerma L; Alos L; Pardo N; Cedrés S; Fan C; Parker JS; Gaba L; Victoria I; Viñolas N; Vivancos A; Arance A; Felip E
Cancer Res; 2017 Jul; 77(13):3540-3550. PubMed ID: 28487385
[TBL] [Abstract] [Full Text] [Related]
16. Role of Surgical Resection in Patients with Single Large Brain Metastases: Feasibility, Morbidity, and Local Control Evaluation.
Pessina F; Navarria P; Cozzi L; Ascolese AM; Maggi G; Rossi M; Riva M; Scorsetti M; Bello L
World Neurosurg; 2016 Oct; 94():6-12. PubMed ID: 27373936
[TBL] [Abstract] [Full Text] [Related]
17. Systematic review of high-intensity focused ultrasound ablation in the treatment of breast cancer.
Peek MC; Ahmed M; Napoli A; ten Haken B; McWilliams S; Usiskin SI; Pinder SE; van Hemelrijck M; Douek M
Br J Surg; 2015 Jul; 102(8):873-82; discussion 882. PubMed ID: 26095255
[TBL] [Abstract] [Full Text] [Related]
18. Predictive value of the Groningen Frailty Indicator for treatment outcomes in elderly patients after head and neck, or skin cancer surgery in a retrospective cohort.
Bras L; Peters TT; Wedman J; Plaat BE; Witjes MJ; van Leeuwen BL; van der Laan BF; Halmos GB
Clin Otolaryngol; 2015 Oct; 40(5):474-82. PubMed ID: 25754107
[TBL] [Abstract] [Full Text] [Related]
19. Genomic microarray analysis on formalin-fixed paraffin-embedded material for uveal melanoma prognostication.
Minca EC; Tubbs RR; Portier BP; Wang Z; Lanigan C; Aronow ME; Triozzi PL; Singh A; Cook JR; Saunthararajah Y; Plesec TP; Schoenfield L; Cawich V; Sulpizio S; Schultz RA
Cancer Genet; 2014; 207(7-8):306-15. PubMed ID: 25442074
[TBL] [Abstract] [Full Text] [Related]
20. Methotrexate-associated B-cell lymphoproliferative disorders presenting in the skin: A clinicopathologic and immunophenotypical study of 10 cases.
Koens L; Senff NJ; Vermeer MH; Willemze R; Jansen PM
Am J Surg Pathol; 2014 Jul; 38(7):999-1006. PubMed ID: 24805861
[TBL] [Abstract] [Full Text] [Related]
[Next]
